Evolutionary Genomics

Evolutionary Genomics Net Change in Cash

The Net Change in Cash of Evolutionary Genomics (FNAM) as of Nov 18, 2026 is 363,057.00 USD. In the previous year, Net Change in Cash was -1,827.00 USD — a change of -19,971.76% (higher).

Net Change in Cash

363,057.00USD

YoY

-19,971.76%

Last updated:

Net Change in Cash of Evolutionary Genomics is 2022 363,057.00 USD. Net Change in Cash of Evolutionary Genomics was 2021 -1,827.00 USD. It decreases by -19,971.76% higher compared to the previous year.

The Evolutionary Genomics Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2015
-455,760.00 USD
Jan 1, 2016
2.05 M USD
Jan 1, 2017
-1.18 M USD
Jan 1, 2018
-748,837.00 USD
Jan 1, 2019
-85,965.00 USD
Jan 1, 2020
170,395.00 USD
Jan 1, 2021
-1,827.00 USD
Jan 1, 2022
363,057.00 USD
The Evolutionary Genomics Net Change in Cash history
YEARNet Change in CashYoY
363,057.00USD-19,971.76%
-1,827.00USD-101.07%
170,395.00USD-298.21%
-85,965.00USD-88.52%
-748,837.00USD-36.39%
-1.18 MUSD-157.33%
2.05 MUSD-550.62%
-455,760.00USD+251,118.17%
-181.42USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Evolutionary Genomics Stock analysis

What does Evolutionary Genomics do? Evolutionary Genomics, Inc. generates revenue through the identification and validation of genes impacting commercially valuable traits in crops for the agriculture industry. The company utilizes its Adapted Traits Platform (ATP) to identify genes that control important traits in plants and animals, focusing on yield increases in corn and rice, drought tolerance, sugar content in tomatoes, and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The firm applies ATP in research projects for agricultural clients seeking improved crop performance. The company targets agricultural industry clients who require gene-based solutions for enhancing crop traits such as yield, drought tolerance, and pest resistance. The Adapted Traits Platform (ATP) is central to the company's product offering, enabling throughput molecular evolution analysis through non-synonymous site (Ka) and synonymous site (Ks) analysis to identify positively selected genes. This platform identifies genes that have successfully adapted to impart new or improved traits in agricultural crops. The firm's research projects include specific applications like yield increases in corn and rice, drought tolerance in crops, and pest resistance in soybeans, cassava, beans, tomatoes, and cotton. Agricultural companies and research institutions are the primary buyers of these gene identification services. Evolutionary Genomics, Inc. focuses on the agriculture industry, specifically targeting clients who need gene validation for crop improvement. The company's services are used to identify genes responsible for commercially valuable traits such as yield, drought tolerance, and pest resistance. The firm's ATP platform is applied in research projects for crops including corn, rice, soybeans, cassava, beans, tomatoes, and cotton. Agricultural clients seeking to enhance their crop traits through gene-based solutions are the key market segment for the company's offerings. Evolutionary Genomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolutionary Genomics stock

Net Change in Cash of Evolutionary Genomics is 363,057.00 USD in 2022.

Net Change in Cash of Evolutionary Genomics changed from -1,827.00 USD to 363,057.00 USD, representing a -19,971.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Evolutionary Genomics since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Evolutionary Genomics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Evolutionary Genomics

All Key Metrics — Evolutionary Genomics